Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV

Cognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (...

Full description

Bibliographic Details
Main Authors: Raha M. Dastgheyb, Alison S. Buchholz, Kathryn C. Fitzgerald, Yanxun Xu, Dionna W. Williams, Gayle Springer, Kathryn Anastos, Deborah R. Gustafson, Amanda B. Spence, Adaora A. Adimora, Drenna Waldrop, David E. Vance, Joel Milam, Hector Bolivar, Kathleen M. Weber, Norman J. Haughey, Pauline M. Maki, Leah H. Rubin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neurology
Subjects:
HIV
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/full
id doaj-838402b711b6400a97c8f66affa763ff
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Raha M. Dastgheyb
Alison S. Buchholz
Kathryn C. Fitzgerald
Yanxun Xu
Yanxun Xu
Dionna W. Williams
Dionna W. Williams
Gayle Springer
Kathryn Anastos
Deborah R. Gustafson
Amanda B. Spence
Adaora A. Adimora
Drenna Waldrop
David E. Vance
Joel Milam
Hector Bolivar
Kathleen M. Weber
Norman J. Haughey
Norman J. Haughey
Pauline M. Maki
Leah H. Rubin
Leah H. Rubin
Leah H. Rubin
spellingShingle Raha M. Dastgheyb
Alison S. Buchholz
Kathryn C. Fitzgerald
Yanxun Xu
Yanxun Xu
Dionna W. Williams
Dionna W. Williams
Gayle Springer
Kathryn Anastos
Deborah R. Gustafson
Amanda B. Spence
Adaora A. Adimora
Drenna Waldrop
David E. Vance
Joel Milam
Hector Bolivar
Kathleen M. Weber
Norman J. Haughey
Norman J. Haughey
Pauline M. Maki
Leah H. Rubin
Leah H. Rubin
Leah H. Rubin
Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
Frontiers in Neurology
HIV
cognition
women
heterogeneity
phenotypes
random forest
author_facet Raha M. Dastgheyb
Alison S. Buchholz
Kathryn C. Fitzgerald
Yanxun Xu
Yanxun Xu
Dionna W. Williams
Dionna W. Williams
Gayle Springer
Kathryn Anastos
Deborah R. Gustafson
Amanda B. Spence
Adaora A. Adimora
Drenna Waldrop
David E. Vance
Joel Milam
Hector Bolivar
Kathleen M. Weber
Norman J. Haughey
Norman J. Haughey
Pauline M. Maki
Leah H. Rubin
Leah H. Rubin
Leah H. Rubin
author_sort Raha M. Dastgheyb
title Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
title_short Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
title_full Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
title_fullStr Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
title_full_unstemmed Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV
title_sort patterns and predictors of cognitive function among virally suppressed women with hiv
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-02-01
description Cognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (NP) test battery completion comprised of: Hopkins Verbal Learning Test-Revised, Trail Making, Symbol Digit Modalities, Grooved Pegboard, Stroop, Letter/Animal Fluency, and Letter-Number Sequencing. Using 17 NP performance metrics (T-scores), we used Kohonen self-organizing maps to identify patterns of high-dimensional data by mapping participants to similar nodes based on T-scores and clustering those nodes. Among VS-WWH, nine clusters were identified (entropy = 0.990) with four having average T-scores ≥45 for all metrics and thus combined into an “unimpaired” profile (n = 311). Impaired profiles consisted of weaknesses in: (1) sequencing (Profile-1; n = 129), (2) speed (Profile-2; n = 144), (3) learning + recognition (Profile-3; n = 137), (4) learning + memory (Profile-4; n = 86), and (5) learning + processing speed + attention + executive function (Profile-5; n = 122). Sociodemographic, behavioral, and clinical variables differentiated profile membership using Random Forest models. The top 10 variables distinguishing the combined impaired vs. unimpaired profiles were: clinic site, age, education, race, illicit substance use, current and nadir CD4 count, duration of effective antiretrovirals, and protease inhibitor use. Additional variables differentiating each impaired from unimpaired profile included: depression, stress-symptoms, income (Profile-1); depression, employment (Profile 2); depression, integrase inhibitor (INSTI) use (Profile-3); employment, INSTI use, income, atazanavir use, non-ART medications with anticholinergic properties (Profile-4); and marijuana use (Profile-5). Findings highlight consideration of NP profile heterogeneity and potential modifiable factors contributing to impaired profiles.
topic HIV
cognition
women
heterogeneity
phenotypes
random forest
url https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/full
work_keys_str_mv AT rahamdastgheyb patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT alisonsbuchholz patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT kathryncfitzgerald patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT yanxunxu patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT yanxunxu patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT dionnawwilliams patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT dionnawwilliams patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT gaylespringer patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT kathrynanastos patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT deborahrgustafson patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT amandabspence patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT adaoraaadimora patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT drennawaldrop patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT davidevance patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT joelmilam patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT hectorbolivar patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT kathleenmweber patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT normanjhaughey patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT normanjhaughey patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT paulinemmaki patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
AT leahhrubin patternsandpredictorsofcognitivefunctionamongvirallysuppressedwomenwithhiv
_version_ 1724274499242688512
spelling doaj-838402b711b6400a97c8f66affa763ff2021-02-11T06:01:55ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-02-011210.3389/fneur.2021.604984604984Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIVRaha M. Dastgheyb0Alison S. Buchholz1Kathryn C. Fitzgerald2Yanxun Xu3Yanxun Xu4Dionna W. Williams5Dionna W. Williams6Gayle Springer7Kathryn Anastos8Deborah R. Gustafson9Amanda B. Spence10Adaora A. Adimora11Drenna Waldrop12David E. Vance13Joel Milam14Hector Bolivar15Kathleen M. Weber16Norman J. Haughey17Norman J. Haughey18Pauline M. Maki19Leah H. Rubin20Leah H. Rubin21Leah H. Rubin22Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, United StatesDivision of Biostatistics and Bioinformatics, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDivision of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United StatesMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United StatesDepartment of Neurology, State University of New York Downstate Health Sciences University, Brooklyn, NY, United States0Division of Infectious Disease and Travel Medicine, Department of Medicine, Georgetown University, Washington, DC, United States1Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States2Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, United States3School of Nursing, University of Alabama at Birmingham, Birmingham, AL, United States4Institute for Health Promotion & Disease Prevention Research, University of Southern California, Los Angeles, CA, United States5Department of Psychiatry & Behavioral Science, University of Miami Miller School of Medicine, Miami, FL, United States6CORE Center, Cook County Health, Hektoen Institute of Medicine, Chicago, IL, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States7Department of Psychiatry and Psychology, University of Illinois at Chicago, Chicago, IL, United StatesDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United StatesCognitive impairment remains frequent and heterogeneous in presentation and severity among virally suppressed (VS) women with HIV (WWH). We identified cognitive profiles among 929 VS-WWH and 717 HIV-uninfected women from 11 Women's Interagency HIV Study sites at their first neuropsychological (NP) test battery completion comprised of: Hopkins Verbal Learning Test-Revised, Trail Making, Symbol Digit Modalities, Grooved Pegboard, Stroop, Letter/Animal Fluency, and Letter-Number Sequencing. Using 17 NP performance metrics (T-scores), we used Kohonen self-organizing maps to identify patterns of high-dimensional data by mapping participants to similar nodes based on T-scores and clustering those nodes. Among VS-WWH, nine clusters were identified (entropy = 0.990) with four having average T-scores ≥45 for all metrics and thus combined into an “unimpaired” profile (n = 311). Impaired profiles consisted of weaknesses in: (1) sequencing (Profile-1; n = 129), (2) speed (Profile-2; n = 144), (3) learning + recognition (Profile-3; n = 137), (4) learning + memory (Profile-4; n = 86), and (5) learning + processing speed + attention + executive function (Profile-5; n = 122). Sociodemographic, behavioral, and clinical variables differentiated profile membership using Random Forest models. The top 10 variables distinguishing the combined impaired vs. unimpaired profiles were: clinic site, age, education, race, illicit substance use, current and nadir CD4 count, duration of effective antiretrovirals, and protease inhibitor use. Additional variables differentiating each impaired from unimpaired profile included: depression, stress-symptoms, income (Profile-1); depression, employment (Profile 2); depression, integrase inhibitor (INSTI) use (Profile-3); employment, INSTI use, income, atazanavir use, non-ART medications with anticholinergic properties (Profile-4); and marijuana use (Profile-5). Findings highlight consideration of NP profile heterogeneity and potential modifiable factors contributing to impaired profiles.https://www.frontiersin.org/articles/10.3389/fneur.2021.604984/fullHIVcognitionwomenheterogeneityphenotypesrandom forest